Schedule 13G ownership disclosure

Taysha Gene Therapies Inc

Security class unavailable · CUSIP: 877619106

Event date: 2023-08-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-23-221528
Form type
SC 13G
Filer
TCG Crossover GP I, LLC
CIK
CIK 1839947
Filed
Aug 25, 2023
Reporting period
Aug 16, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub